Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil vs Sildenafil Preference in Chinese Men with ED
NCT01352507Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jun 2011
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tadalafil in erectile dysfunction (ED) (2 arms), sponsored by Eli Lilly and Company. Primary endpoint: Percentage of Participants Preferring Tadalafil Over Sildenafil at Week 18. Started Jun 2011; status: completed.
02
Drugs
tadalafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT01352507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01352507.